Clinical Features

Targeting the ‘Achilles heel’ of childhood AML using Systems Biology

Acute myeloid leukaemia (AML)is the leading cause of blood cancer-related mortality in children.

aml

Written by Dr. Luke Jones, Irish Cancer Society Research Fellow at Systems Biology Ireland, University College Dublin

Dr. Oleksii Rukhlenko, Research Scientist at Systems Biology Ireland, University College Dublin

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free